Ashley N. Abel is CEO and co-founder of Metri Bio, where she works on the next generation of endometrial therapeutics. She holds a PhD in Genetics from Yale University and has conducted research in stem cell and early embryonic development.
Ashley N. Abel is CEO and co-founder of Metri Bio, where she works on the next generation of endometrial therapeutics. She holds a PhD in Genetics from Yale University and has conducted research in stem cell and early embryonic development.